382 related articles for article (PubMed ID: 33569813)
1. Tau in the gut, does it really matter?
Derkinderen P; Rolli-Derkinderen M; Chapelet G; Neunlist M; Noble W
J Neurochem; 2021 Jul; 158(2):94-104. PubMed ID: 33569813
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy.
Lionnet A; Wade MA; Corbillé AG; Prigent A; Paillusson S; Tasselli M; Gonzales J; Durieu E; Rolli-Derkinderen M; Coron E; Duchalais E; Neunlist M; Perkinton MS; Hanger DP; Noble W; Derkinderen P
Acta Neuropathol Commun; 2018 Jul; 6(1):65. PubMed ID: 30037345
[TBL] [Abstract][Full Text] [Related]
3. The gut in Parkinson's disease: Bottom-up, top-down, or neither?
Leclair-Visonneau L; Neunlist M; Derkinderen P; Lebouvier T
Neurogastroenterol Motil; 2020 Jan; 32(1):e13777. PubMed ID: 31854093
[TBL] [Abstract][Full Text] [Related]
4. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
5. The nature of catecholamine-containing neurons in the enteric nervous system in relationship with organogenesis, normal human anatomy and neurodegeneration.
Natale G; Ryskalin L; Busceti CL; Biagioni F; Fornai F
Arch Ital Biol; 2017 Sep; 155(3):118-130. PubMed ID: 29220864
[TBL] [Abstract][Full Text] [Related]
6. Enteric synucleinopathy: from trendy concept to real entity.
de Guilhem de Lataillade A; Lebouvier T; Noble W; Leclair-Visonneau L; Derkinderen P
Free Neuropathol; 2020 Jan; 1():. PubMed ID: 37283671
[TBL] [Abstract][Full Text] [Related]
7. Tau phosphorylation and aggregation as a therapeutic target in tauopathies.
Badiola N; Suárez-Calvet M; Lleó A
CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):727-40. PubMed ID: 20942789
[TBL] [Abstract][Full Text] [Related]
8. Tau and tauopathies.
Arendt T; Stieler JT; Holzer M
Brain Res Bull; 2016 Sep; 126(Pt 3):238-292. PubMed ID: 27615390
[TBL] [Abstract][Full Text] [Related]
9. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
10. Tau accumulates in Crohn's disease gut.
Prigent A; Chapelet G; De Guilhem de Lataillade A; Oullier T; Durieu E; Bourreille A; Duchalais E; Hardonnière K; Neunlist M; Noble W; Kerdine-Römer S; Derkinderen P; Rolli-Derkinderen M
FASEB J; 2020 Jul; 34(7):9285-9296. PubMed ID: 32436623
[TBL] [Abstract][Full Text] [Related]
11. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
Williams DR
Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
[TBL] [Abstract][Full Text] [Related]
12. The Gut and Nonmotor Symptoms in Parkinson's Disease.
Klingelhoefer L; Reichmann H
Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.
Arotcarena ML; Dovero S; Prigent A; Bourdenx M; Camus S; Porras G; Thiolat ML; Tasselli M; Aubert P; Kruse N; Mollenhauer B; Trigo Damas I; Estrada C; Garcia-Carrillo N; Vaikath NN; El-Agnaf OMA; Herrero MT; Vila M; Obeso JA; Derkinderen P; Dehay B; Bezard E
Brain; 2020 May; 143(5):1462-1475. PubMed ID: 32380543
[TBL] [Abstract][Full Text] [Related]
14. From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson's Disease.
Montalbán-Rodríguez A; Abalo R; López-Gómez L
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279293
[TBL] [Abstract][Full Text] [Related]
15. Tau and tauopathies.
Lee G; Leugers CJ
Prog Mol Biol Transl Sci; 2012; 107():263-93. PubMed ID: 22482453
[TBL] [Abstract][Full Text] [Related]
16. Parallel manifestations of neuropathologies in the enteric and central nervous systems.
Natale G; Pasquali L; Paparelli A; Fornai F
Neurogastroenterol Motil; 2011 Dec; 23(12):1056-65. PubMed ID: 21951862
[TBL] [Abstract][Full Text] [Related]
17. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
18. Tauopathies as clinicopathological entities.
Irwin DJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
[TBL] [Abstract][Full Text] [Related]
19. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
[TBL] [Abstract][Full Text] [Related]
20. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]